Company Overview
Snapshot
Founded in November 2018 by Itai Cohen and Allen Hazan, Gavan operates with 51–200 employees. The company has raised $8M across two funding rounds from five investors. In December 2024, Gavan secured Series A funding from investors including MoreVC and Lever VC.
Business overview
Gavan is an Agriculture & Food Technologies company focused on developing alternative fat solutions. The company utilizes an exclusive protein extraction platform to derive proteins from plants in their natural state. These proteins are then combined to create Fatrix, a plant-based oleogel that binds vegetable oil and water. Fatrix is designed to offer exceptional performance in texture, taste neutrality, scale optimization, and cost efficiency, serving the food processing and ingredients markets with novel, sustainable protein solutions.
Strategic signal
In December 2024, Gavan successfully closed an $8M Series A funding round. This significant capital injection, led by MoreVC and Lever VC, signals strong investor confidence in Gavan's innovative plant-based fat solution, Fatrix, and its potential to commercialize and scale within the rapidly expanding sustainable proteins market. The funding is a critical validation of the company's technology and its strategic position to address the growing demand for healthier and more sustainable food ingredients.
Log in to access full profile ›Company Intelligence Q&A
- What is Gavan's primary product?
- Gavan's primary product is Fatrix, a plant-based oleogel that serves as a multifunctional fat solution. It is created using an exclusive protein extraction platform that combines plant proteins with vegetable oil and water.
- When was Gavan founded and by whom?
- Gavan was founded in November 2018 by Itai Cohen and Allen Hazan.
- What was Gavan's most recent funding round?
- In December 2024, Gavan raised $8M in Series A funding. Investors in this round included MoreVC and Lever VC.
- How does Gavan's Fatrix product differ from other alternatives?
- Gavan's Fatrix uses 20 times less protein than prevalent alternatives on the market, while demonstrating exceptional performance in texture, taste neutrality, scale optimization, and cost efficiency.
- Which investors participated in Gavan's Series A funding round?
- Gavan's Series A funding round in December 2024 included investments from MoreVC and Lever VC.